ICCC earnings date and last-quarter result: next report 2026-08-13, last quarter beat, P/E -186.12. Updated 2026-07-23.
ImmuCell (ICCC) Research Hub
ImmuCell (ICCC) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 10.24 USD (-0.10%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -186.12, market cap 0.10B. This hub links to the full technical, earnings and options research available for ICCC.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 10.24 USD (-0.10%) |
| 52-week range | 9.25 USD – 11.8 USD |
| Trend regime | Range |
| 14-day RSI | 54.7 (Neutral) |
| Trailing P/E | -186.12 |
| Market cap | 0.10B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-13 |
Available research for ICCC
Covered Call on ICCC: how it works, illustrative setup around the real 10.24 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ICCC: how it works, illustrative setup around the real 10.24 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ICCC: how it works, illustrative setup around the real 10.24 USD price, max profit/loss, breakeven and when to use it. Educational.
ICCC technical analysis: range, last 10.24 USD, RSI 54.7, 52w range 9.25 USD–11.8 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is ICCC in?
ImmuCell (ICCC) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ICCC in an uptrend or downtrend?
As of 2026-10-26, ICCC is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ICCC's trailing P/E ratio?
ICCC's trailing P/E is -186.12, with a market cap of 0.10B. See the earnings research page for full valuation detail.
When does ICCC next report earnings?
ICCC is next scheduled to report earnings on 2026-08-13.